AOD-9604

• Supports the breakdown of stored fat (lipolysis)
• Helps reduce the formation of new fat cells (lipogenesis)
• May aid in overall fat loss and body recomposition
• Preserves lean muscle mass during weight management
• May support healthy metabolism and energy balance
• Does not increase growth hormone levels, reducing risk of HGH-related side effects
• Generally well tolerated in clinical studies
• Can be used as part of a comprehensive wellness or weight optimization plan

• Pregnant or breastfeeding women, as safety has not been established.
• Individuals with active cancer or a history of growth hormone–sensitive tumors, since increased GH and IGF-1 levels may stimulate abnormal cell growth.
• Individuals with severe heart, liver, or kidney disease, where fluid retention may exacerbate symptoms.
• Anyone with a known allergy or hypersensitivity to AOD-9604 or its components.
• Individuals with endocrine disorders or hormonal imbalances should only use AOD-9604 under medical supervision.

• Changes in Appetite: A temporary change in hunger, particularly in the early stages of treatment.
• Mild injection site reactions, such as redness, swelling, or irritation (if administered subcutaneously).
• Digestive discomfort or nausea (more common with oral formulations).
• Transient Fatigue or Lethargy: Some individuals may feel tired or sluggish during the adjustment period.
• Mild Headaches: Occasionally reported, especially at higher doses or with dehydration.
• Allergic reactions (rare; may include rash or localized itching).

• Follow medical guidance closely: Always use AOD-9604 under the supervision of a qualified healthcare provider and follow the prescribed dosage exactly.
• Start low, adjust gradually: Beginning with a lower dose (as advised by your clinician) allows the body to adapt and may reduce early side effects.
• Rotate injection sites: If using the injectable form, alternate injection areas (e.g., abdomen, thigh) to minimize redness or irritation.
• Use proper injection technique: Clean the area with alcohol, use sterile equipment, and inject subcutaneously (under the skin, not into muscle) to reduce discomfort.
• Stay hydrated: Adequate water intake may support metabolic processes and reduce mild headaches or fatigue.
• Monitor your body’s response: Track any changes in energy, appetite, or mood and report persistent or unusual symptoms to your provider.
• Avoid unsupervised stacking: Do not combine AOD-9604 with other peptides or medications without professional approval.
• Store properly: Keep the peptide refrigerated as directed; improper storage may reduce stability and increase irritation risk.
• Pause if needed: If you experience significant or unexpected effects, stop use and consult your healthcare provider before continuing.

• AOD-9604 is a peptide fragment derived from human growth hormone (HGH), specifically amino acids 176–191, which are responsible for the hormone’s fat-metabolizing activity. 
• Unlike full-length HGH, AOD-9604 does not stimulate growth or increase IGF-1 levels—it acts only on fat metabolism pathways.

Mechanism of Action

• Stimulates lipolysis: AOD-9604 enhances the body’s natural process of breaking down stored fat (triglycerides) into usable energy.
• Inhibits lipogenesis: It helps reduce the rate at which new fat cells form, limiting fat storage.
• Targets adipose tissue: The peptide’s activity is selective to fat cells and does not influence muscle or organ growth.
• Metabolic regulation: It may improve the way the body uses fat as a primary energy source, supporting overall metabolic efficiency.

Clinical Overview

• AOD-9604 has been studied for its potential to support fat reduction and improve body composition without the adverse effects typically associated with full growth hormone therapy.
• Because it does not affect blood sugar levels or growth-related pathways, it is often considered a safer alternative for metabolic and body optimization goals.

Weeks 4–6: Early Benefits

• Subtle changes in body composition may begin to appear after 4–6 weeks of consistent use.

Weeks 8–12: Visible and Functional Changes

• Noticeable results often develop over 8–12 weeks, depending on lifestyle factors such as diet, activity, and metabolic rate.